Literature DB >> 27743633

Cross-cultural adaptation and validation of the Japanese version of the Toronto Extremity Salvage Score (TESS) for patients with malignant musculoskeletal tumors in the upper extremities.

Toru Akiyama1, Kosuke Uehara2, Koichi Ogura3, Yusuke Shinoda2, Shintaro Iwata4, Kazuo Saita1, Yoshikazu Tanzawa5, Fumihiko Nakatani5, Tsukasa Yonemoto4, Hirotaka Kawano2, Aileen M Davis6, Akira Kawai5.   

Abstract

BACKGROUND: The Toronto Extremity Salvage Score (TESS) is a widely used disease-specific patient-completed questionnaire for the assessment of physical function in patients with musculoskeletal tumors; however, there had not been the validated Japanese version of the TESS. The aim of this study was to validate the Japanese version of the TESS in patients with musculoskeletal tumors in the upper extremity.
METHODS: After developing a Japanese version of the TESS, the questionnaire was administered to 53 patients to examine its reliability and validity in comparison with the Musculoskeletal Tumor Society (MSTS) scoring system and Short Form-36 (SF-36).
RESULTS: Test-retest reliability with intraclass correlation coefficient (0.93) and internal consistency with Cronbach's alpha (0.90) were excellent. Factor analysis showed that the construct structure consisted of 3-item clusters, and the Akaike Information Criterion network also demonstrated that the items could be divided into 3 domains according to their content. The TESS strongly correlated with the MSTS rating scale (r = 0.750; P < 0.001) and the SF-36 physical functioning scale (r = 0.684; P < 0.001). However, as expected, the TESS had low correlations with the SF-36 mental health and role-emotional subscales and the MSTS scoring system manual dexterity domain.
CONCLUSIONS: Our study suggests that the TESS is a reliable and valid instrument to measure patient-reported physical functioning in patients with upper extremity sarcoma.
Copyright © 2016 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27743633     DOI: 10.1016/j.jos.2016.09.012

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  7 in total

1.  Editorial: Importance of Validating the Scores We Use to Assess Patients with Musculoskeletal Tumors.

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2019-04       Impact factor: 4.176

2.  Reliability and Validity of the Musculoskeletal Tumor Society Scoring System for the Upper Extremity in Japanese Patients.

Authors:  Kosuke Uehara; Koichi Ogura; Toru Akiyama; Yusuke Shinoda; Shintaro Iwata; Eisuke Kobayashi; Yoshikazu Tanzawa; Tsukasa Yonemoto; Hirotaka Kawano; Akira Kawai
Journal:  Clin Orthop Relat Res       Date:  2017-05-30       Impact factor: 4.176

3.  The critical difference in the DASH (Disabilities of the Arm, Shoulder, and Hand) outcome measure after essential upper extremity tumor surgery.

Authors:  Koichi Ogura; Mohamed A Yakoub; Alexander B Christ; Tomohiro Fujiwara; Zarko Nikolic; Patrick J Boland; Edward A Athanasian; John H Healey
Journal:  J Shoulder Elbow Surg       Date:  2021-01-20       Impact factor: 3.507

4.  What Are the Minimum Clinically Important Differences in SF-36 Scores in Patients with Orthopaedic Oncologic Conditions?

Authors:  Koichi Ogura; Mohamed A Yakoub; Alexander B Christ; Tomohiro Fujiwara; Zarko Nikolic; Patrick J Boland; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2020-09       Impact factor: 4.755

5.  Cross-Cultural Adaptation, Translation, and Validation of the Toronto Extremity Salvage Score for Extremity Bone and Soft Tissue Tumor Patients in Netherlands.

Authors:  Julie J Willeumier; C W P G van der Wal; Robert J P van der Wal; P D S Dijkstra; Thea P M Vliet Vlieland; Michiel A J van de Sande
Journal:  Sarcoma       Date:  2017-07-20

6.  Cross-Cultural Validation of the Italian Version of the Bt-DUX: A Subjective Measure of Health-Related Quality of Life in Patients Who Underwent Surgery for Lower Extremity Malignant Bone Tumour.

Authors:  Mattia Morri; Peter Willem Bekkering; Marco Cotti; Matilde Meneghini; Enrico Venturini; Alessandra Longhi; Elisabetta Mariani; Cristiana Forni
Journal:  Cancers (Basel)       Date:  2020-07-23       Impact factor: 6.639

7.  Cross-cultural adaptation and validation of the Musculoskeletal Tumor Society (MSTS) scoring system and Toronto Extremity Salvage Score (TESS) for musculoskeletal sarcoma patients in Greece.

Authors:  Ioanna K Bolia; Olga D Savvidou; Hyunwoo P Kang; Nikolaos Chatzichristodoulou; Panayiotis D Megaloikonomos; Evanthia Mitsiokapa; Andreas F Mavrogenis; Panayiotis J Papagelopoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.